DAX23.092 -0,8%Est505.515 -1,0%MSCI World4.343 -0,1%Top 10 Crypto11,72 -3,4%Nas22.273 +0,9%Bitcoin73.428 -0,6%Euro1,1515 ±0,0%Öl62,56 -1,0%Gold4.066 -0,3%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
NVIDIA 918422 Rheinmetall 703000 Siemens Energy ENER6Y DroneShield A2DMAA RENK RENK73 Amazon 906866 Alphabet A (ex Google) A14Y6F Deutsche Telekom 555750 Tesla A1CX3T Lufthansa 823212 Palantir A2QA4J BASF BASF11 Infineon 623100 SAP 716460 TKMS thyssenkrupp Marine Systems TKMS00
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX geht bei über 23.000 Punkten ins Wochenende -- Wall Street höher -- Portfolio von NVIDIA -- Bitcoin & Co. tiefrot -- D-Wave, Novo Nordisk, Siemens Energy, DroneShield, Rheinmetall, RENK im Fokus
Top News
Bitcoin-Holding-Aktien wie Strategy und Metaplanet: Kapitalabflüsse in Milliardenhöhe drohen Bitcoin-Holding-Aktien wie Strategy und Metaplanet: Kapitalabflüsse in Milliardenhöhe drohen
Die Highlights und Lowlights im TecDAX: Gewinner und Verlierer der KW 47 im Überblick Die Highlights und Lowlights im TecDAX: Gewinner und Verlierer der KW 47 im Überblick
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Novozymes A-S (B) Un Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
54,00 EUR +1,50 EUR +2,86 %
BMN
Novozymes A-S (B) Un jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Smartphone
KGV78,32Div. Rendite0,96%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA0YF6B

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS6701081092

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolNVZMY

Novozymes A-S (B) Un Aktien News

DatumMeistgelesen
GlobeNewswireInterim report for Q1 2023
GlobeNewswireNovozymes’ and Chr. Hansen’s shareholders approve combination to create a leading global biosolutions partner
GlobeNewswireResolutions from Novozymes A/S’ Extraordinary Shareholders’ Meeting on 30 March 2023
GlobeNewswireCombination between Novozymes and Chr. Hansen approved by the Novozymes shareholders
GlobeNewswireUpdate on the combination of Novozymes and Chr. Hansen: U.S. antitrust regulation waiting period has expired, supporting the path to completion
GlobeNewswireTrading by management and close relations of management
GlobeNewswireTrading by management and close relations of management
GlobeNewswireTrading by management and close relations of management
GlobeNewswireTrading by management and close relations of management
GlobeNewswireTrading by management and close relations of management
GlobeNewswireTrading by management and close relations of management
GlobeNewswireTrading by management and close relations of management
GlobeNewswireTrading by management and close relations of management
GlobeNewswireTrading by management and close relations of management
GlobeNewswireTrading by management and close relations of management
GlobeNewswireInvitation to an extraordinary shareholders’ meeting of Novozymes A/S
GlobeNewswirePublication of exemption document in relation to the proposed combination of Novozymes and Chr. Hansen, confirmation of outlook for 2023 and proposed candidates to the Board of Directors of the combin
GlobeNewswireTrading by management and close relations of management
GlobeNewswireTrading by management and close relations of management
GlobeNewswireTrading by management and close relations of management
GlobeNewswireResolutions from Novozymes A/S’ Annual Shareholders’ Meeting 2023
GlobeNewswireTrading by management and close relations of management
GlobeNewswireTrading by management and close relations of management
GlobeNewswireTrading by management and close relations of management
GlobeNewswireTrading by management and close relations of management
GlobeNewswireTrading by management and close relations of management
GlobeNewswireTrading by management and close relations of management
GlobeNewswireTrading by management and close relations of management
GlobeNewswireTrading by management and close relations of management
GlobeNewswireTrading by management and close relations of management
GlobeNewswireTrading by management and close relations of management
GlobeNewswireTrading by management and close relations of management
GlobeNewswireTrading by management and close relations of management
GlobeNewswireTrading by management and close relations of management
GlobeNewswireTrading by management and close relations of management
GlobeNewswireTrading by management and close relations of management
GlobeNewswireTrading by management and close relations of management
GlobeNewswireTrading by management and close relations of management

Novozymes A-S (B) Un News

Novozymes A-S (B) Un News: auf dieser Seite finden Sie alle Novozymes A-S (B) Un News und Nachrichten zur Novozymes A-S (B) Un Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Novozymes A-S (B) Un News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Novozymes A-S (B) Un News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.